{"id":8539,"date":"2017-11-07T08:56:07","date_gmt":"2017-11-07T13:56:07","guid":{"rendered":"https:\/\/medicarereport.org\/?p=8539"},"modified":"2017-11-07T08:56:07","modified_gmt":"2017-11-07T13:56:07","slug":"trump-takes-on-hospitals-the-facts-behind-fight-over-340b-drug-discounts","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=8539","title":{"rendered":"Trump takes on hospitals: the facts behind fight over 340B drug discounts"},"content":{"rendered":"<p>(By Casey Ross for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">There\u2019s at least one unassailable fact in the battle over the federal 340B drug discount program: $1.6 billion is a lot of money. <a href=\"https:\/\/www.statnews.com\/2017\/11\/06\/340b-drug-discounts-fight\/?utm_source=STAT+Newsletters&amp;utm_campaign=84ac2f9ff3-Pharmalot&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-84ac2f9ff3-149624405\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7795\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg\" alt=\"\" width=\"300\" height=\"201\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Casey Ross for STAT) There\u2019s at least one unassailable fact in the battle over the federal 340B drug discount<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,10,6,15],"tags":[],"class_list":["post-8539","post","type-post","status-publish","format-standard","hentry","category-legal-actionscourt-decisions","category-legislative-update","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8539"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8539\/revisions"}],"predecessor-version":[{"id":8540,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8539\/revisions\/8540"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}